MilliporeSigma
  • Home
  • Search Results
  • Susceptibility and mode of binding of the Mycobacterium tuberculosis cysteinyl transferase mycothiol ligase to tRNA synthetase inhibitors.

Susceptibility and mode of binding of the Mycobacterium tuberculosis cysteinyl transferase mycothiol ligase to tRNA synthetase inhibitors.

Bioorganic & medicinal chemistry letters (2011-03-12)
Maria-Teresa Gutierrez-Lugo, Carole A Bewley
ABSTRACT

The cysteinyl transferase mycothiol ligase, or MshC, catalyzes the fourth step in the biosynthesis of the small molecular weight thiol mycothiol. MshC is essential for growth of Mycobacterium tuberculosis. Two groups of known aminoacyl tRNA synthetase inhibitors were evaluated for inhibition of M. tuberculosis MshC including aminoacyl adenosine analogs and natural products. Using enzyme assays, isothermal titration calorimetry and NMR, we show that MshC is selectively inhibited by cysteinyl sulfamoyl adenosine, and that discrimination occurs at the amino acid moiety.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Ochratoxin A−BSA conjugate from Aspergillus ochraceus
Sigma-Aldrich
Borrelidin, from Streptomyces parvulus, ≥98% (HPLC)
Sigma-Aldrich
Mupirocin, ≥92% (HPLC), powder
Supelco
Ochratoxin A, from Aspergillus ochraceus, reference material
Sigma-Aldrich
Ochratoxin A, from Petromyces albertensis, ≥98% (HPLC)